International Structural Genomics Consortium Announces $48.9 Million in Additional Funding to Continue the Search for New Medicines, Consortium Also Welcomes Two New Member Companies - MarketWatch

"The international Structural Genomics Consortium (SGC) today announced $48.9 million in new funding has been attained. This renewed investment will allow the SGC to further develop its open access research program to support drug discovery and the development of new medicines. The announcement comes as the SGC on June 30 successfully completed its second phase of funding (2007-2011). Formed in 2004, the SGC is supported by public and private sector funding and all of its findings are made available to the global research community without restriction....New members of the consortium are Eli Lilly Canada and Pfizer Inc. The other consortium funders comprise the Canadian Institutes for Health Research, GlaxoSmithKline, the Novartis Research Foundation, the Ontario Ministry of Research and Innovation, and the Wellcome Trust...."